Literature DB >> 9716377

GTP-binding-protein-coupled receptor kinase 2 (GRK2) binds and phosphorylates tubulin.

K Haga1, H Ogawa, T Haga, H Murofushi.   

Abstract

Tubulin was found to bind to a glutathione S-transferase fusion protein containing the carboxy-terminal domain of GTP-binding-protein-coupled receptor kinase 2 (GRK2) (residues 467-689), which is known to contain a pleckstrin homology site and to bind GTP-binding protein betagamma subunits. The binding of tubulin to the fusion protein was not affected by GTP-binding protein betagamma subunits, indicating that tubulin and betagamma subunits bind GRK2 independently. Western-blotting analysis with anti-GRK2 Ig indicated that GRK2 was copurified with tubulin through the polymerization-depolymerization procedure. Tubulin was phosphorylated by GRK2, in contrast with the facts that the known substrates of GRK2 are restricted to activated forms of GTP-binding-protein-coupled receptors and that tubulin is a poor substrate for most kinases. GRK2 did not phosphorylate microtubule-associated proteins (MAPs), under conditions where MAPs were well phosphorylated by endogenous kinases copurified with tubulin. The Km for tubulin was estimated to be 3 microM, and 1.3 mol phosphate/tubulin dimer was incorporated. The phosphorylation of tubulin was stimulated by betagamma subunits and agonist-bound muscarinic receptors. Phosphorylated tubulin could be polymerized into microtubules, and polymerized tubulin was also phosphorylated by GRK2.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9716377     DOI: 10.1046/j.1432-1327.1998.2550363.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  18 in total

Review 1.  G-protein coupled receptor kinases as modulators of G-protein signalling.

Authors:  M Bünemann; M M Hosey
Journal:  J Physiol       Date:  1999-05-15       Impact factor: 5.182

Review 2.  GRK2: multiple roles beyond G protein-coupled receptor desensitization.

Authors:  Tama Evron; Tanya L Daigle; Marc G Caron
Journal:  Trends Pharmacol Sci       Date:  2012-01-23       Impact factor: 14.819

3.  Visual arrestin binding to microtubules involves a distinct conformational change.

Authors:  Susan M Hanson; Derek J Francis; Sergey A Vishnivetskiy; Candice S Klug; Vsevolod V Gurevich
Journal:  J Biol Chem       Date:  2006-02-06       Impact factor: 5.157

Review 4.  G protein-coupled receptor kinases: more than just kinases and not only for GPCRs.

Authors:  Eugenia V Gurevich; John J G Tesmer; Arcady Mushegian; Vsevolod V Gurevich
Journal:  Pharmacol Ther       Date:  2011-08-26       Impact factor: 12.310

5.  The GRK2 Overexpression Is a Primary Hallmark of Mitochondrial Lesions during Early Alzheimer Disease.

Authors:  Mark E Obrenovich; Hector H Palacios; Eldar Gasimov; Jerzy Leszek; Gjumrakch Aliev
Journal:  Cardiovasc Psychiatry Neurol       Date:  2010-03-03

6.  G protein-coupled receptor kinase 2-mediated phosphorylation of ezrin is required for G protein-coupled receptor-dependent reorganization of the actin cytoskeleton.

Authors:  Sarah H Cant; Julie A Pitcher
Journal:  Mol Biol Cell       Date:  2005-04-20       Impact factor: 4.138

Review 7.  The evolving impact of g protein-coupled receptor kinases in cardiac health and disease.

Authors:  Priscila Y Sato; J Kurt Chuprun; Mathew Schwartz; Walter J Koch
Journal:  Physiol Rev       Date:  2015-04       Impact factor: 37.312

Review 8.  Regulation of Lrp6 phosphorylation.

Authors:  Christof Niehrs; Jinlong Shen
Journal:  Cell Mol Life Sci       Date:  2010-03-14       Impact factor: 9.261

9.  Interaction between metabotropic glutamate receptor 7 and alpha tubulin.

Authors:  Julie A Saugstad; Sufang Yang; Jan Pohl; Randy A Hall; P Jeffrey Conn
Journal:  J Neurochem       Date:  2002-03       Impact factor: 5.372

Review 10.  Insights into cerebrovascular complications and Alzheimer disease through the selective loss of GRK2 regulation.

Authors:  Mark E Obrenovich; Ludis A Morales; Celia J Cobb; Justin C Shenk; Gina M Méndez; Kathryn Fischbach; Mark A Smith; Eldar K Qasimov; George Perry; Gjumrakch Aliev
Journal:  J Cell Mol Med       Date:  2008-10-06       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.